Article tools
Author information
Published in Volume 98, Issue 11 (December 1,1996)
J. Clin. Invest. 98(11): 2640-2647 (1996). doi:10.1172/JCI119085.
Copyright © 1996, The American Society for Clinical Investigation.

Research Article

Induction of central tolerance by intrathymic inoculation of adenoviral antigens into the host thymus permits long-term gene therapy in Gunn rats.

Y Ilan, P Attavar, M Takahashi, A Davidson, M S Horwitz, J Guida, N R Chowdhury and J R Chowdhury

Marion Bessin Liver Research Center, Albert Einstein College of Medicine, Bronx, New York 10461, USA.

Published December 1, 1996

Recombinant adenoviruses are highly efficient at transferring foreign genes in vivo. However, duration of gene expression is limited by the host antiviral immune response which precludes expression upon viral readministration. We tested the feasibility of prolonging gene expression by induction of central tolerance to adenoviral antigens in bilirubin-UDP-glucuronosyltransferase-1 (BUGT1)-deficient Gunn rats. Tolerance was induced by intraperitoneal injection of antilymphocyte serum, followed by intrathymic inoculation of one of the following: a recombinant adenovirus (Ad), adenovirus human UDP-glucuronosyltransferase (Ad-hBUGT1) carrying the hBUGT1 gene; a protein extract of the same virus; or viral infected hepatocytes. Controls received intrathymic injections of normal saline. After 12 d all groups were injected intravenously with 5 x 10(9) pfu of either Ad-hBUGT1 or adenovirus beta-galactosidase (Ad-LacZ) (expressing the Escherichia coli beta-galactosidase [LacZ] gene). In all three groups of tolerized rats, hBUGT1 was expressed in the liver after administration of Ad-hBUGT1, with glucuronidation of biliary bilirubin of above 95%. Serum bilirubin levels decreased from 7.2 to 1.8 mg/dl within 1 wk and remained low for 7 wk. Similar findings were observed following repeat injections given on days 45 and 112. In control rats serum bilirubin levels were reduced for only 4 wk, and viral readministration was ineffective. In all tolerized groups, but not in controls, there was a marked inhibition of appearance of neutralizing antibodies and cytotoxic lymphocytes against the recombinant adenovirus. Injection of wild type adenovirus-5 (Ad5) into the tolerized rats elicited a wild type-specific cytotoxic lymphocyte response. This is the first demonstration of Ad-directed long-term correction of an inherited metabolic disease following central tolerization with thymic antigen.

This article Copyright © 1996, The American Society for Clinical Investigation.

Articles that cite
this article:

Oral Immune Regulation toward Disease-Associated Antigens: Results of Phase I Clinical Trials in Crohn's Disease and Chronic Hepatitis
YARON Ilan
Ann N Y Acad Sci 1029(1):286. [CrossRef]

Oral tolerization ameliorates liver disorders associated with chronic graft versus host disease in mice
Arnon Nagler, Mark Pines, Uri Abadi, Orit Pappo, Michael Zeira, Elazar Rabbani, Dean Engelhardt, Meir Ohana, Namita Roy Chowdhury, Jayanta Roy Chowdhury
Hepatol 31(3):641. [CrossRef]

Viral gene delivery
David S Strayer
Expert Opin Invest Drugs 8(12):2159. [CrossRef]

Adenoviral vectors: development and application
Wei-Wei Zhang
Expert Opin Invest Drugs 6(10):1419. [CrossRef]

Advances in adenoviral vectors for cancer gene therapy
Guadalupe Bilbao, Jesús Gómez-navarro, Juan Luis Contreras, David T Curiel
eotp 7(12):1427. [CrossRef]

Mixed hematopoietic molecular chimerism results in permanent transgene expression from retrovirally transduced hepatocytes in mice
Virginie Pichard, Marta Bellodi-privato, Jérôme Gournay, Nicolas Ferry
J Gene Med 8(4):425. [CrossRef]

Gene therapy for liver enzyme deficiencies: what have we learned from models for Crigler–Najjar and tyrosinemia?
Tuan Huy Nguyen, Nicolas Ferry
Expert Review of Gastroenterology & Hepatology 1(1):155. [CrossRef]

Growth Factors Gene Delivery to Enhance Grafting Circumventing Adenovirus Immune Response to Achieve Long-Term Correction of Genetic Diseases
Florence Paillard
Hum Gene Ther 9(4):453. [CrossRef]

Liver-Directed Gene Transfer Vectors
Nicolas Ferry, Jean Michel Heard
Hum Gene Ther 9(14):1975. [CrossRef]

PEGylation of E1-Deleted Adenovirus Vectors Allows Significant Gene Expression on Readministration to Liver
Maria A. Croyle, Narendra Chirmule, Yi Zhang, James M. Wilson
Hum Gene Ther 13(15):1887. [CrossRef]

Immunological hurdles to lung gene therapy
S. Ferrari, U. Griesenbach, D. M. Geddes, E. Alton
Clin Exp Immunol 132(1):1. [CrossRef]

Summary Report of a Symposium: Genes and Gene Delivery for Diseases of Alcoholism
Fulton T. Crews
Alcohol Clin Exp Res 25(12):1778. [CrossRef]

Correction of Enzymatic and Lysosomal Storage Defects in Fabry Mice by Adenovirus-Mediated Gene Transfer
Robin J. Ziegler, Nelson S. Yew, Chester Li, Maribeth Cherry, Patricia Berthelette, Helen Romanczuk, Yiannis A. Ioannou, Kenneth M. Zeidner, Robert J. Desnick, Seng H. Cheng
Hum Gene Ther 10(10):1667. [CrossRef]

Segregation of Mechanisms for Cytotoxic T Lymphocyte Killing between Lungs and Regional Lymph Nodes Subsequent to Intratracheal Delivery of Adenovirus 2 Vector
Xinhai Wang, Peter Hillemeyer, David W. Pascual
Viral Immunol 16(4):525. [CrossRef]

Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: Correlation of genotype to phenotype
Ajit Kadakol, Siddhartha S. Ghosh, Baljit S. Sappal, Girish Sharma, Jayanta Roy Chowdhury, Namita Roy Chowdhury
Hum Mutat 16(4):297. [CrossRef]

Gene transfer to schwann cells after peripheral nerve injury: A delivery system for therapeutic agents
Jesper Sørensen, Georg Haase, Christian Krarup, Helene Gilgenkrantz, Axel Kahn, Henning Schmalbruch
Ann Neurol 43(2):205. [CrossRef]

Suppression of the Immune Response Against Exogenous Desmoglein 3 in Desmoglein 3 Knockout Mice: An Implication for Gene Therapy
Manabu Ohyama, Takayuki Ota, Miyo Aoki, Kazuyuki Tsunoda, Reiko Harada, Shigeo Koyasu, Takeji Nishikawa, Masayuki Amagai
J Invest Dermatol 120(4):610. [CrossRef]

Immunomodulation of experimental colitis: the role of NK1.1 liver lymphocytes and surrogate antigens - bystander effect
Amir Shlomai, Shivti Trop, Israel Gotsman, Oded Jurim, Judith Diment, Ruslana Alper, Elazar Rabbani, Dean Engelhardt, Yaron Ilan
J Pathol 195(4):498. [CrossRef]


Stuart Turvey, Jeremy Fry, Kathryn Wood
Curr Opin Organ Transpl 4(1):50. [CrossRef]

Successful gene therapy of the Gunn rat byin vivo neonatal hepatic gene transfer using murine oncoretroviral vectors
Marta Bellodi-privato, Dominique Aubert, Virginie Pichard, Anne Myara, François Trivin, Nicolas Ferry
Hepatol 42(2):431. [CrossRef]